Madeleine V Pahl1, Nosratola D Vaziri, Jun Yuan, Sharon G Adler. 1. Department of Medicine, Division of Nephrology and Hypertension, UCI Medical Center, 101 The City Drive, Building 53, Room 125, Rt 81, Orange, CA 92868, USA. mpahl@uci.edu
Abstract
BACKGROUND AND OBJECTIVES: Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects. RESULTS: Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function. CONCLUSIONS: Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.
BACKGROUND AND OBJECTIVES:Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects. RESULTS: Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function. CONCLUSIONS: Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.
Authors: M A Weterman; N Ajubi; I M van Dinter; W G Degen; G N van Muijen; D J Ruitter; H P Bloemers Journal: Int J Cancer Date: 1995-01-03 Impact factor: 7.396
Authors: Samir M Abdelmagid; Mary F Barbe; Israel Arango-Hisijara; Thomas A Owen; Steven N Popoff; Fayez F Safadi Journal: J Cell Physiol Date: 2007-01 Impact factor: 6.384
Authors: T A Owen; S L Smock; S Prakash; L Pinder; D Brees; D Krull; T A Castleberry; Y C Clancy; S C Marks; F F Safadi; S N Popoff Journal: Crit Rev Eukaryot Gene Expr Date: 2003 Impact factor: 1.807
Authors: Patrick A Ott; Omid Hamid; Anna C Pavlick; Harriet Kluger; Kevin B Kim; Peter D Boasberg; Ronit Simantov; Elizabeth Crowley; Jennifer A Green; Thomas Hawthorne; Thomas A Davis; Mario Sznol; Patrick Hwu Journal: J Clin Oncol Date: 2014-09-29 Impact factor: 44.544
Authors: Walison N Silva; Pedro H D M Prazeres; Ana E Paiva; Luiza Lousado; Anaelise O M Turquetti; Rodrigo S N Barreto; Erika Costa de Alvarenga; Maria A Miglino; Ricardo Gonçalves; Akiva Mintz; Alexander Birbrair Journal: Exp Dermatol Date: 2018-04-30 Impact factor: 3.960
Authors: April A N Rose; Matthew G Annis; Zhifeng Dong; Francois Pepin; Michael Hallett; Morag Park; Peter M Siegel Journal: PLoS One Date: 2010-08-10 Impact factor: 3.240